Randomized esrd trial comparing CBT alone versus with buprenorphine (recover)

Ended Cooperative Agreement Awarded Last action

Award ID
U01DK123786
Recipient
Awarding agency
Obligated
$3,875,678

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Funding agency
National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
Place of performance
Seattle, WA 98195, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$167,197
Amendment -$621,362
Amendment $0
Amendment $621,362
Amendment $621,362
Amendment $621,362
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Original award $2,800,151
Show all 18

Subawards

Subrecipient Amount Awarded
New York University Randomized ESRD Trial COmparing CBT alone VERsus with buprenorphine (RECOVER). $73,360
University Of New Mexico $71,131
The Rogosin Institute Inc. $31,694
University Of New Mexico $111,445
University Of Pittsburgh - Of The Commonwealth System Of Higher Education $24,772
The Trustees Of The University Of Pennsylvania $57,405

Quick answers

Who received award U01DK123786?

U01DK123786 was awarded to University Of Washington by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 24, 2019.

How much is award U01DK123786 worth?

$3,875,678 has been obligated on U01DK123786.

Which agency awarded U01DK123786?

National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) awarded U01DK123786, with funding from National Institute on Drug Abuse (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award